Literature DB >> 33183134

Adipose Tissue-Derived Mesenchymal Stem Cell Concentrated Conditioned Medium Alters the Expression Pattern of Glutamate Regulatory Proteins and Aquaporin-4 in the Retina after Mild Traumatic Brain Injury.

Kumar Abhiram Jha1, Jordy Gentry1, Nobel A Del Mar1, Anton Reiner1, Nicolas Sohl2, Rajashekhar Gangaraju1.   

Abstract

Concentrated conditioned media from adipose tissue-derived mesenchymal stem cells (ASC-CCM) show promise for retinal degenerative diseases. In this study, we hypothesized that ASC-CCM could rescue retinal damage and thereby improve visual function by acting through Müller glia in mild traumatic brain injury (mTBI). Adult C57Bl/6 mice were subjected to a 50-psi air pulse on the left side of the head, resulting in an mTBI. After blast injury, 1 μL (∼100 ng total protein) of human ASC-CCM was delivered intravitreally and followed up after 4 weeks for visual function assessed by electroretinogram and histopathological markers for Müller cell-related markers. Blast mice that received ASC-CCM, compared with blast mice that received saline, demonstrated a significant improvement in a- and b-wave response correlated with a 1.3-fold decrease in extracellular glutamate levels and a concomitant increase in glutamine synthetase (GS), as well as the glutamate transporter (GLAST) in Müller cells. Additionally, an increase in aquaporin-4 (AQP4) in Müller cells in blast mice received saline restored to normal levels in blast mice that received ASC-CCM. In vitro studies on rMC-1 Müller glia exposed to 100 ng/mL glutamate or RNA interference knockdown of GLAST expression mimicked the increased Müller cell glial fibrillary acidic protein (a marker of gliosis) seen with mTBI, and suggested that an increase in glutamate and/or a decrease in GLAST might contribute to the Müller cell activation in vivo. Taken together, our data suggest a novel neuroprotective role for ASC-CCM in the rescue of the visual deficits and pathologies of mTBI via restoration of Müller cell health.

Entities:  

Keywords:  Müller; confocal; glutamate; inflammation; mesenchymal; neurodegeneration

Mesh:

Substances:

Year:  2021        PMID: 33183134      PMCID: PMC8165480          DOI: 10.1089/neu.2020.7309

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   4.869


  5 in total

Review 1.  Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases.

Authors:  Carl Randall Harrell; Vladislav Volarevic; Valentin Djonov; Ana Volarevic
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 2.  Visual deficits after traumatic brain injury.

Authors:  Pratheepa Kumari Rasiah; Ben Geier; Kumar Abhiram Jha; Rajashekhar Gangaraju
Journal:  Histol Histopathol       Date:  2021-02-18       Impact factor: 2.303

Review 3.  Conditioned medium derived from bovine umbilical mesenchymal stem cells as an alternative source of cell-free therapy.

Authors:  Dwi Liliek Kusindarta; Hevi Wihadmadyatami
Journal:  Vet World       Date:  2021-10-05

Review 4.  Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.

Authors:  Sally L Elshaer; Salma H Bahram; Pranav Rajashekar; Rajashekhar Gangaraju; Azza B El-Remessy
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

5.  A Long-Term Safety and Efficacy Report on Intravitreal Delivery of Adipose Stem Cells and Secretome on Visual Deficits After Traumatic Brain Injury.

Authors:  Pratheepa Kumari Rasiah; Kumar Abhiram Jha; Jordy Gentry; Nobel A Del Mar; Tanisha Townsend; Kwame E Torgbe; Anton Reiner; Rajashekhar Gangaraju
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.